FLUTAMIDE (Cipla USA Inc.)
Welcome to the PulseAid listing for the FLUTAMIDE drug offered from Cipla USA Inc.. This Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
NON-PROPRIETARY NAME: | FLUTAMIDE |
SUBSTANCE NAME: | FLUTAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-09-21 |
END MARKETING DATE: | 0000-00-00 |
FLUTAMIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | FLUTAMIDE from Cipla USA Inc. |
LABELER NAME: | Cipla USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/1) |
START MARKETING DATE: | 2016-09-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69097-915_8c90da76-d928-486c-92d1-576e8f4d137d |
PRODUCT NDC: | 69097-915 |
APPLICATION NUMBER: | ANDA075780 |
Other FLUTAMIDE Pharmaceutical Manufacturers / Labelers: